MRNA Investor Relations (IR)

• Moderna, Inc. investor relations →
  investors.modernatx.com
• Latest results release →
  Q2 2026, published Jul 31, 2026
• SEC filings on EDGAR →
  10-K, 10-Q and 8-K filing history

• Q2 2026 reported Jul 31, 2026

  Revenue $145M · EPS −$1.97

  Press release for Q2 2026 →
• Q1 2026 reported May 1, 2026

  Revenue $389M · EPS −$3.40

  Press release for Q1 2026 →
• Q4 2025 reported Feb 13, 2026

  Revenue $678M · EPS −$2.11

  Press release for Q4 2025 →
• Q3 2025 reported Nov 6, 2025

  Revenue $1.02B · EPS −$0.51

  Press release for Q3 2025 →

All MRNA earnings →

R40 does not score Moderna, Inc. on its latest reported quarter — capital expenditure and cash flow are too large relative to revenue for the combined score to be meaningful.